https://pubmed.ncbi.nlm.nih.gov/38114833
Scientists achieved a nuclear-fusion breakthrough by repeatedly igniting a fusion reaction, leading to a net energy gain.
https://pubmed.ncbi.nlm.nih.gov/38114831
This abstract is not available for summarization as it is not a scientific abstract, but rather a commentary written by Jeremy Tregoning about his experiences as a new professorship and how he drew inspiration from the fictional worlds of Dark Souls and Star Wars.
https://pubmed.ncbi.nlm.nih.gov/38114830
This abstract suggests that the scientists in question have chosen not to use ChatGPT, possibly due to concerns about the AI model’s potential inaccuracies and the need for human oversight in research.
https://pubmed.ncbi.nlm.nih.gov/38114828
In their natural environment, some viruses have been found to incorporate and transport bacterial defense systems, allowing for the transfer and proliferation of these defense mechanisms within bacterial populations.
https://pubmed.ncbi.nlm.nih.gov/38114827
A new species of parasitic copepod, Ergasilus lyraephorus, is discovered on the gills of the Longtail Knifefish in Northeast Brazil, representing the first report of an ergasilid parasitizing this host and the first parasitic copepod found on a host belonging to the family Sternopygidae.
https://pubmed.ncbi.nlm.nih.gov/38114826
The distal fistula risk score (D-FRS), a tool for predicting postoperative pancreatic fistula (POPF) after distal pancreatectomy, shows acceptable accuracy in distinguishing patients who will develop POPF in a nationwide cohort, particularly in the preoperative setting.
https://pubmed.ncbi.nlm.nih.gov/38114825
Microbial α-amylases, with their wide industrial applications, face challenges in scaling up for mass production, but potential solutions include optimizing bioprocessing, enhancing enzyme properties, and utilizing inexpensive substrates.
https://pubmed.ncbi.nlm.nih.gov/38114824
Serum monoclonal proteins based on immunofixation electrophoresis can serve as significant prognostic indicators for newly diagnosed B-cell non-Hodgkin lymphoma, identifying patients with poor prognosis and guiding clinical treatment decisions.